Harvard Bioscience (HBIO) Current Taxes (2010 - 2023)
Harvard Bioscience (HBIO) posted quarterly Current Taxes of $398000.0 for Q2 2023, up 665.38% year-over-year from $52000.0 in Q2 2022, and down 43.14% quarter-over-quarter from $700000.0 in Q1 2023.
Harvard Bioscience (HBIO) Current Taxes (2010 - 2023) Analysis & Trends
Harvard Bioscience (HBIO) has reported Current Taxes for 14 consecutive years, with $398000.0 the latest figure, recorded in Q2 2023.
- In Q2 2023, Current Taxes rose 665.38% year-over-year to $398000.0; the TTM figure through Jun 2023 stood at $398000.0 (up 665.38% YoY), while the FY2021 annual figure was $224000.0, down 21.68% from the prior year.
- Current Taxes retreated to $398000.0 in Q2 2023 per HBIO's latest filing, from $700000.0 in the prior quarter.
- Across five years, Current Taxes topped out at $1.3 million in Q1 2019 and bottomed at $52000.0 in Q2 2022.
- Historically, Current Taxes has averaged $505250.0 across 5 years, with a median of $471000.0 in 2021.
- Annual changes were most pronounced in 2019 — Current Taxes soared 3121.05% — and 2022, when it tumbled 90.44%.
- Harvard Bioscience's Current Taxes stood at $609000.0 in 2019, then sank by 53.04% to $286000.0 in 2020, then slipped by 21.68% to $224000.0 in 2021, then plunged by 76.79% to $52000.0 in 2022, then soared by 665.38% to $398000.0 in 2023.
- Business Quant data shows HBIO's Current Taxes at $398000.0 in Q2 2023, $700000.0 in Q1 2023, and $52000.0 in Q2 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 133.48 Bn | 128.26 Bn | 1.96 Bn | - |
| 2 | Becton Dickinson | 52.15 Bn | 51.29 Bn | 2.32 Bn | - |
| 3 | Alcon | 35.59 Bn | 34.24 Bn | 1.68 Bn | 228.00 Mn |
| 4 | Resmed | 33.67 Bn | 32.20 Bn | 861.22 Mn | 98.11 Mn |
| 5 | Medline | 28.56 Bn | 25.88 Bn | 2.22 Bn | - |
| 6 | West Pharmaceutical Services | 24.97 Bn | 24.53 Bn | 329.20 Mn | 64.70 Mn |
| 7 | Solventum | 15.34 Bn | 14.94 Bn | 1.29 Bn | - |
| 8 | Cooper Companies | 14.83 Bn | 14.69 Bn | 735.40 Mn | - |
| 9 | Baxter International | 13.59 Bn | 11.44 Bn | 1.03 Bn | - |
| 10 | Harvard Bioscience | 34.35 Mn | 27.85 Mn | 12.63 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 398,000.00 |
| Mar 31, 2023 | 700,000.00 |
| Jun 30, 2022 | 52,000.00 |
| Mar 31, 2022 | 141,000.00 |
| Dec 31, 2021 | 224,000.00 |
| Sep 30, 2021 | 246,000.00 |
| Jun 30, 2021 | 544,000.00 |
| Mar 31, 2021 | 206,000.00 |
| Dec 31, 2020 | 286,000.00 |
| Sep 30, 2020 | 749,000.00 |
| Jun 30, 2020 | 969,000.00 |
| Mar 31, 2020 | 624,000.00 |
| Dec 31, 2019 | 609,000.00 |
| Sep 30, 2019 | 385,000.00 |
| Jun 30, 2019 | 612,000.00 |
| Mar 31, 2019 | 1.34 Mn |
| Dec 31, 2018 | 978,000.00 |
| Sep 30, 2018 | 576,000.00 |
| Jun 30, 2018 | 19,000.00 |
| Mar 31, 2018 | 538,000.00 |